Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to do so could be grounds for compensation. Our lawyers are operating challenging to have these hurt by the drug the compensation they are entitled to.













Whilst bleeding can be a common complication linked with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This signifies that, within the occasion of an emergency, sufferers might be at danger for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.













If you or possibly a loved a single suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For much More inspiring ideas details, contact us today to possess your case reviewed, cost-free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenditures. Furthermore, they are looking for punitive damages, that are usually awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a protected anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.













Visit this page for much more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki